期刊文献+

二十二碳六烯酸药物递送系统研究进展

Research progress of drug delivery system of docosahexaenoic acid
原文传递
导出
摘要 二十二碳六烯酸(DHA)因具有多种潜在的药理活性及营养价值,在食品和医药领域都有重要的应用。然而,DHA是一种长链不饱和脂肪酸,含多个双键,其稳定性和水溶性差使其在医药领域和食品工业的应用受到很大限制。本文重点将负载DHA的药物传递系统如在纳米粒、脂质体、微乳、纳米乳、水凝胶和聚合物胶束纳米递送系统中的应用研究,以及将DHA与其他药物共同封装、寻求改善现有传递系统性能的研究进行综述,为DHA的研究和应用提供参考。 Due to the various potential pharmacological activities and nutritional value, docosahexaenoic acid(DHA) has important applications in both food and pharmaceutical fields. However, since DHA is a long-chain unsaturated fatty acid containing multiple double bonds, its stability and water solubility are relatively poor, making its application in both the pharmaceutical field and the food industry extremely limited. This article focuses on the application of nano drug delivery systems loaded with DHA, such as nanoparticles, liposomes, microemulsions, nanoemulsions, hydrogels and self-assembled micelles. The studies that co-encapsulate DHA with other drugs to improve the performance of existing delivery systems were also reviewed in order to provide reference for the research and application of DHA.
作者 史礼君 李金鑫 刘萌芽 刘改枝 SHI Li-jun;LI Jin-xin;LIU Meng-ya;LIU Gai-zhi(School of Pharmacy,Henan University of Chinese Medicine,Zhengzhou 450046,China)
出处 《中国新药杂志》 CAS CSCD 北大核心 2022年第15期1487-1494,共8页 Chinese Journal of New Drugs
基金 国家自然科学基金资助项目(81803740) 河南省高等学校重点科研项目(22A350015) 中国博士后科学基金面上项目(2020M682311)。
关键词 二十二碳六烯酸 药物递送系统 研究进展 docosahexaenoic acid drug delivery system research progress
  • 相关文献

参考文献2

二级参考文献38

  • 1赵凯存,宋振玉.双氢青蒿素在人的药代动力学及与青蒿素的比较[J].药学学报,1993,28(5):342-346. 被引量:23
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5233
  • 3DYERBERG J, BANG HO, HJORNE N. Fatty acid composition of the plasma lipids in Greenland Eskimos[ J]. Am J Clin Nurr, 1975,28(9) :958 -966.
  • 4LAVIE C J, MILANI RV,MEHRA MR, et al. Omega-3 polyunsaturated fatty acids and cardiovascular diseases [ J]. J Am CoU Cardiol, 2009,54 ( 7 ) : 585-594.
  • 5MOZAFFARIAN D, RIMM EB. Fish intake, contaminants, and human health : evaluating the risks and the benefits [J]. JAMA, 2006,296(15) :1885-1899.
  • 6SOLVAY HEALTHCARE LIMITED. Omacor: summary of product characteristics[ EB/OL]. [ 2008-04-17 ]. http ://emc. medicines, org. uk/medicine/10312/SPC/omacor/.
  • 7BURR ML, FEHILY AM, GILBERT JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet And Reinfarction Trial (DART) [J]. Lancet, 1959,2 (8666) :757 -761.
  • 8GISSI-PREVENZIONE INVESTIGATORS. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial [ J ]. Lancet, 1999,354 ( 9177 ) : 447-455.
  • 9MARCHIOLI R,BARZI F,BOMBA E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction : time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico ( GISSI ) -Prevenzione [ J ]. Circulation, 2002, 105 ( 16 ) : 1897-1903.
  • 10KRIS-ETHERTON PM, HARRIS WS, APPEL LJ,for the Nutri tion Committee. fish consumption, fish oil, omega-3 fatty acids and cardiovascular disease [ J]. Circulation, 2002,106 (21) 2747-2757.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部